Company news

Endonovo Therapeutics, Inc. news in 2020

Endonovo Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Endonovo Therapeutics’ Offers FDA Cleared Solution to Opioid Epidemic Which Has Significantly Increased During the COVID Pandemic.

October 8, 2020

Endonovo Therapeutics Announces Encore Live Webinar of Baylor College of Medicine Study For Patients Undergoing Cardiothoracic Surgery Showing Reduction of Pain and Opioid Use With Significant Reduction of Length of Stay Using SofPulse®

September 9, 2020

Endonovo Therapeutics, Inc. Announces Second Quarter Fiscal 2020 Financial Results

August 20, 2020

Endonovo Therapeutics Announces Significant Results From Study Showing 70% Reduction of Morphine Equivalent Dose and 2 Day Reduction of Length of Stay at Hospitals Using SofPulse®

July 27, 2020

Endonovo Therapeutics Announces Effectiveness of Registration of Equity Credit Line and Ceasing Variable Convertible Note Financing

July 21, 2020

Endonovo Therapeutics Announces First Quarter Fiscal 2020 Financial Results

June 15, 2020

Endonovo Therapeutics Announces International Expansion with Distribution Agreement for SofPulse® in Taiwan, Republic of China

June 1, 2020

Endonovo Therapeutics Enters into $10 million Equity Line Agreement with Cavalry Fund

May 26, 2020

Endonovo Therapeutics Announces Positive 2019 Fiscal Results

May 4, 2020

Endonovo Therapeutics Announces Eight Additional Hospitals Approved Use of SofPulse® at Their Facilities

April 16, 2020

Endonovo Therapeutics seeks Intensive Care Unit Partners for Investigational Adjunctive Treatment for Severe Respiratory Inflammatory Complications for COVID-19 Patients.

March 25, 2020

Endonovo to Donate SofPulse® Units for Investigational Use to Evaluate Inhibition of Inflammatory Symptoms Associated with COVID-19

March 16, 2020

Endonovo Therapeutics Files 8K With SEC Regarding SofPulse®

March 2, 2020

Endonovo Therapeutics Introduces Support of SofPulse® With A New Ancillary Multi-Use Patient Brace From Protex

February 24, 2020

Endonovo Therapeutics Begins Process For Medical Reimbursements

February 20, 2020

Endonovo Therapeutics Announces collaborating with a Stanford University sponsored Orthopedic Shoulder and Knee Study

February 13, 2020

Endonovo Therapeutics announces its collaboration with Major Universities for the Evaluation of SofPulse® for Orthopedic Surgeries

February 10, 2020

Endonovo Therapeutics Reduces Debt

February 4, 2020

Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers

January 30, 2020

Endonovo Therapeutics Announces First SofPulse® Sales to a Veterans Medical Center

January 27, 2020

Endonovo Therapeutics Announces Issuance of Broad Patent Covering Electromagnetic Treatment of Multiple Sclerosis

January 14, 2020

Endonovo Therapeutics Announces Issuance of U.S. Patent Covering Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke

January 7, 2020

Decks in 2020